These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10852664

  • 21. Towards 2001: will ACE inhibitors have a role in atherosclerosis treatment?
    Sharpe N.
    Int J Clin Pract Suppl; 1998 May; 94():26-31. PubMed ID: 9926442
    [Abstract] [Full Text] [Related]

  • 22. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J.
    Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
    [Abstract] [Full Text] [Related]

  • 23. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE, Julius S.
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [Abstract] [Full Text] [Related]

  • 24. Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?
    Fox K, Ferrari R, Yusuf S, Borer JS.
    Eur Heart J; 2006 Sep; 27(18):2154-7. PubMed ID: 16905555
    [Abstract] [Full Text] [Related]

  • 25. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Sep; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 26. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 27. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D, Weber R, Enseleit F, Lüscher TF.
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [Abstract] [Full Text] [Related]

  • 28. Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function.
    Poelzl G, Frick M, Lackner B, Huegel H, Alber HF, Mair J, Herold M, Schwarzacher SP, Pachinger O, Weidinger F.
    Int J Cardiol; 2006 Mar 22; 108(1):48-54. PubMed ID: 16516697
    [Abstract] [Full Text] [Related]

  • 29. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM.
    J Hum Hypertens; 2004 Sep 22; 18(9):599-606. PubMed ID: 15190263
    [Abstract] [Full Text] [Related]

  • 30. Evidence for benefits of perindopril in hypertension and its complications.
    Laurent S.
    Am J Hypertens; 2005 Sep 22; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
    [Abstract] [Full Text] [Related]

  • 31. Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes.
    Cheetham C, O'Driscoll G, Stanton K, Taylor R, Green D.
    Clin Sci (Lond); 2001 Jan 22; 100(1):13-7. PubMed ID: 11115412
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF, Garbin U, Nava MC, Stranieri C, Pellegrini M, Boccioletti V, Luchetta ML, Fabrizzi P, Lo Cascio V, Cominacini L.
    Am J Hypertens; 2007 Apr 22; 20(4):443-50. PubMed ID: 17386354
    [Abstract] [Full Text] [Related]

  • 35. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
    Buus NH, Jørgensen CG, Mulvany MJ, Sørensen KE.
    Blood Press; 2007 Apr 22; 16(2):106-13. PubMed ID: 17612909
    [Abstract] [Full Text] [Related]

  • 36. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
    Hirota T, Ohki K, Kawagishi R, Kajimoto Y, Mizuno S, Nakamura Y, Kitakaze M.
    Hypertens Res; 2007 Jun 22; 30(6):489-96. PubMed ID: 17664851
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. BANFF: an update.
    Anderson T.
    Can J Cardiol; 1999 Apr 22; 15 Suppl B():29B-30B. PubMed ID: 10350682
    [Abstract] [Full Text] [Related]

  • 40. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Lüscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B.
    Circulation; 1996 Aug 01; 94(3):258-65. PubMed ID: 8759064
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.